SCHEMBL434353

SCHEMBL434353

Fc1ccc([C]2CC2)c(F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
IDO1 P14902 2/20 0.39
AGXT P21549 2/20 0.39
TDP2 O95551 1/20 0.39
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
USP2 O75604 1/20 0.38
DHFR P00374 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
LMNA P02545 1/20 0.38
TTR P02766 1/20 0.38
ALB P02768 1/20 0.38
HMGB1 P09429 1/20 0.38
HPGD P15428 1/20 0.38
CXCL12 P48061 1/20 0.38
KMT2A Q03164 1/20 0.38
HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL435076 0.91 ALDH1A1 (0.39) ALDH1A1IDO1AGXTTDP2CES2
SCHEMBL436723 0.91 MAOA (0.41) ALDH1A1IDO1AGXTTDP2CES2
SCHEMBL435253 0.89 MAOA (0.42) ALDH1A1IDO1AGXTTDP2CES2
SCHEMBL9135463 0.81 ALDH1A1 (0.52) ALDH1A1IDO1AGXTCES2CES1
SCHEMBL15566852 0.80 CA9 (0.42) ALDH1A1CES2CES1KDM4ECA1
SCHEMBL8640755 0.79 PARP1 (0.40) ALDH1A1TDP2PDE3BPDE3A
SCHEMBL433272 0.76 KMO (0.40) KMT2ACYP19A1CYP11B1CYP11B2KMO
SCHEMBL3019057 0.76 PTGS2 (0.44) CYP19A1CYP11B1CYP11B2PDE3BPDE3A
SCHEMBL17514566 0.76 NISCH (0.49) KDM4EMEN1HPGDKMT2ACYP19A1
SCHEMBL27776245 0.76 CYP19A1 (0.35) CA1CA2KMT2ACA9CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180368410-A1 MICROBIOCIDAL OXADIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2018-12-27 US disclosed
EP-2595984-A1 MICROBICIDES Syngenta Participations AG (CH) 2013-05-29 EP disclosed
EP-2595985-A1 ISOXAZOLE, ISOTHIAZOLE, FURANE AND THIOPHENE COMPOUNDS AS MICROBICIDES Syngenta Participations AG (CH) 2013-05-29 EP disclosed
WO-2012010567-A1 ISOXAZOLE, ISOTHIAZOLE, FURANE AND THIOPHENE COMPOUNDS AS MICROBICIDES SYNGENTA PARTICIPATIONS AG (CH) 2012-01-26 WO disclosed
WO-2012010568-A1 MICROBICIDES SYNGENTA PARTICIPATIONS AG (CH) 2012-01-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180368410-A1 MICROBIOCIDAL OXADIAZOLE DERIVATIVES PRF1, NOX1, ARG1 ALDH1A1 476/4885IDO1 9/4885AGXT 2352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.